Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $43.5300 (1%) ($43.5300 - $43.5300) on Tue. Jun. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.27% (three month average) | RSI | 47 | Latest Price | $43.5300(1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.1% a day on average for past five trading days. | Weekly Trend | HALO declines -2.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(46%) IWO(41%) IWM(40%) IWC(39%) IWN(39%) | Factors Impacting HALO price | HALO will decline at least -1.135% in a week (0% probabilities). VIXM(-19%) UUP(-8%) VXX(-7%) TBT(-3%) GLD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.135% (StdDev 2.27%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $45.03 | 5 Day Moving Average | $44.32(-1.78%) | 10 Day Moving Average | $44.84(-2.92%) | 20 Day Moving Average | $45.03(-3.33%) | To recent high | -9.9% | To recent low | 26% | Market Cap | $5.949b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |